Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given.
Falls in antibodies after vaccination are expected and do not necessarily mean people are more vulnerable to disease, but the researchers are concerned that if the declines persist the effectiveness of the vaccines may diminish.
The UCL Virus Watch study found that antibodies generated by two doses of the Oxford/AstraZeneca and Pfizer/BioNTech vaccines started to wane as early as six weeks after the second shot, in some cases falling more than 50% over 10 weeks.
The researchers stress that both vaccines are extremely effective against Covid, but say the findings support plans for a booster campaign this autumn, particularly for those who were vaccinated early and with the Oxford/AstraZeneca shot.
“We know levels of antibodies start high and drop substantially,” said Prof Rob Aldridge, an infectious disease epidemiologist at University College London. “We’re concerned that if they carry on dropping at the rate we’ve seen, the protective effects of the vaccines will start to drop too, and the big question is, when is that going to happen?”
Interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) last month encouraged the NHS to prepare for an autumn booster programme, but a final decision on whether to proceed has not been made. It is unclear whether protection from vaccines has weakened enough to warrant boosters and many experts argue the doses are needed more urgently in other countries.
The UCL team analysed blood from 605 vaccinated people mostly in their 50s and 60s. They found that antibody levels varied widely between patients, but a double dose of Pfizer/BioNTech tended to produce far more antibodies against the coronavirus than two shots of the Oxford/AstraZeneca vaccine.
Three to six weeks after full vaccination with Pfizer, antibody levels typically stood at about 7,500 units per millilitre (ml), but more than halved to 3,320 units per ml after 10 weeks. For AstraZeneca, antibody levels peaked at about 1,200 units per ml and typically fell to 190 units per ml after 10 weeks. Since publishing the results in a letter to the Lancet, the researchers have seen the same trend in a further 4,500 participants in the study.
While antibody levels are important for protection, the immune system has other defences that are built up after infection or vaccination. It is normal for antibody levels to wane over time and for the immune system to “remember” the infection with memory B cells. Should the virus invade, these cells rapidly churn out antibodies targeted at the virus. Further protection comes from T cells, which destroy infected cells and limit the severity of disease.
“Antibodies are not the perfect measure of risk; we don’t know if there’s a magic number, as it were, where the risk of infection or hospitalisation becomes important,” said Aldridge. “But we think these data support the JCVI case for boosters, with priority for the clinically vulnerable, the over-70s, and all people living in residential care homes for older adults.”
The findings have been considered by the JCVI but are unlikely to have a major impact on discussions over boosters. A loss of antibodies is a warning sign that vaccines may wear off over time but does not say when that point comes. Public health authorities will not know for sure until people who had their second shots early in the rollout start turning up in hospitals. A decision on the booster programme is expected before that happens.
The COVID-19 pandemic highlighted the need for fast-produced and adaptable vaccines that could be equally distributed around the world. Developing an efficient mRNA vaccine that is effective, thermostable, and has fewer side effects strongly [...]
Engineered nanomaterials (ENMs) have found their applications in various technologies and consumer products. Manipulating chemicals at the nanoscale range introduces unique characteristics to these materials and makes them desirable for technological applications. With the [...]
Smart nanoparticle shows that intermittent fasting may protect the heart from damage during chemotherapy
Although chemotherapy can be a lifesaving treatment for patients with cancer, some of these medications can damage the heart. A team led by researchers at Massachusetts General Hospital (MGH) recently developed a nanoparticle probe [...]
When the autumn booster programme begins next month, many people are likely to receive Moderna’s new bivalent vaccine, designed to protect against the original Covid strain and the more transmissible Omicron variant. As Covid continues [...]
Scientists of the department of Advanced Organ Bioengineering and Therapeutics (TechMed Centre) recently published a novel cancer immune therapy in the scientific journal Nature Communications ("Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages"). [...]
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a contact lens that can capture and detect exosomes, nanometer-sized vesicles found in bodily secretions which have the potential for being diagnostic cancer [...]
Among the total number of deaths caused by different types of cancer, esophageal cancer is the sixth most significant. Several conventional treatments, such as radiotherapy, chemotherapy, and surgery have multiple side effects, including off-target [...]
Cell membrane-coated nanoparticles, applied in targeted drug delivery strategies, combine the intrinsic advantages of synthetic nanoparticles and cell membranes. Although stem cell-based delivery systems were highlighted for their targeting capability in tumor therapy, inappropriate [...]
When babies in the African countries of Guinea Bissau and Uganda were given the tuberculosis vaccine, something remarkable happened. Instead of the vaccine only protecting against the target bacteria – Myocbacterium tuberculosis – the tuberculosis vaccine offered broad protection against a [...]
Thousands of years ago, across the Eastern Mediterranean, multiple Bronze Age civilizations took a distinct turn for the worse at around the same time. The Old Kingdom of Egypt and the Akkadian Empire both collapsed, and there was [...]
IN OCTOBER 2014, virologist Edward Holmes took a tour of the Huanan Seafood Wholesale Market in Wuhan, a once relatively overlooked city of about 11 million people in the central Chinese province of Hubei. The market would [...]
Self-healable ionic sensing materials with fatigue resistance are imperative in robotics and soft electronics for extended service life. The existing artificial ionic skins with self-healing capacity were prepared by network reconfiguration, constituting low-energy amorphous [...]
As demand for solar energy rises around the world, scientists are working to improve the performance of solar devices—important if the technology is to compete with traditional fuels. But researchers face theoretical limits on [...]
When shrimp shell nanoparticles were mixed into cement paste, the material became substantially stronger — researchers propose an innovation that could lead to less seafood waste and fewer carbon dioxide emissions from concrete production. [...]
A black-and-white video shared on social media showed a microscopic corkscrew-shaped helix as it appeared to consume a sperm, transport it, and ultimately lead the little swimmer into the wall of an [...]
Polymers containing quantum dots (QDs) are considered crucial components of next-generation consumer items, but ambiguity remains regarding how these compounds may negatively affect public health and the environment. A pre-proof paper from the Journal of Hazardous [...]